Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China · Delayed Price · Currency is CNY 17.80
+0.24 (1.37%)
Oct 23, 2026, 3:00 PM CST
SHA:600645 Market Cap
SHA:600645 has a market cap or net worth of 8.11 billion as of October 22, 2026. It is the 9,181st most valuable company in the world and the 1,919th biggest in China. Its market cap has decreased by 25.37% in one year.
Market Cap
8.11B
Enterprise Value
6.41B
Revenue
1.40B
Global Rank
Country Rank
#1,919 China
PE Ratio
71.12
ChartMarket Cap Chart
Since May 9, 2006, SHA:600645's market cap has increased from 610.06M to 8.11B, an increase of 1,230.18%. That is a compound annual growth rate of 13.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 8.11B | -29.37% |
| Dec 31, 2025 | 11.49B | 30.57% |
| Dec 31, 2024 | 8.80B | -7.24% |
| Dec 29, 2023 | 9.49B | 19.17% |
| Dec 30, 2022 | 7.96B | -32.61% |
| Dec 31, 2021 | 11.81B | 28.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 8.90B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.85B |
| Chongqing Genrix Biopharmaceutical | 8.58B |
| Shanghai OPM Biosciences | 8.41B |
| Liaoning Chengda Biotechnology | 8.30B |
| Chengdu Easton Biopharmaceuticals | 8.15B |
| Novogene | 7.96B |
| Jiangxi Fushine Pharmaceutical | 7.88B |